BRSK2 and lung carcinoma: Another novel autoantigen was discovered in 2005 (Fig. 1) by Sabater’s group (Sabater et al. 2005), who diagnosed serum BR serine/threonine kinase 2 (BRK2) antibodies in a patient with a “limbic syndrome” in conjunction with lung cancer crucial for neuronal transmission and development.